FDC Limited received US FDA approval for its Abbreviated New Drug Application for Cefixime for Oral Suspension.
The approval covers two dosage strengths: 100 mg/5 mL and 200 mg/5 mL formulations.
This regulatory filing was submitted to BSE and NSE under SEBI Listing Regulations.